Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis

American Journal of Hematology

Volumn 81, Issue 1, 2006, Pages 59-61

  Henzan, Tomoko ^a   Nagafuji, Koji ^a   Tsukamoto, Hiroshi ^a   Miyamoto, Toshihiro ^a   Gondo, Hisashi ^a   Imashuku, Shinsaku ^b   Harada, Mine ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Kyoto City Institute of Health and Environment Science   (Japan)

Author keywords

Cytokines; Hemophagocytic lymphohistiocytosis; Infliximab; Tumor necrosis factor

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; ETOPOSIDE; INFLIXIMAB; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; PANCYTOPENIA; PLASMAPHERESIS; PRIORITY JOURNAL; RARE DISEASE; REFRACTORY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PLASMA EXCHANGE; REMISSION INDUCTION;

EID: 30444454994     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20462     Document Type: Article

References (14)

1. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18(1):29-33.
2. Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 2000;72(1):1-11.
3. Arico M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol 2002;119(1):180-188.
4. Ramanan AV, Schneider R. Macrophage activation syndrome - what's in a name! J Rheumatol 2003;30(12):2513-2516.
5. Akashi K, Hayashi S, Gondo H, et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 1994;87(2):243-250.
6. Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997;89(11):4100- 4103.
7. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114(4): 761-769.
8. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993; 82(8):2319-2323.
9. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999;93(6): 1869-1874.
10. Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100(7): 2367-2373.
11. Markham A, Lamb HM. Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs 2000;59(6): 1341-1359.
12. Murray KM, Dahl SL. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Ann Pharmacother 1997;31(11):1335-1338.
13. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 2001;28(9):2120-2124.
14. Henter JI, Karlen J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans'-cell histiocytosis with etanercept. N Engl J Med 2001;345(21): 1577-1578.